$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Water-soluble polymeric carriers for drug delivery 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C07D-305/14
출원번호 US-0464270 (1995-06-05)
발명자 / 주소
  • Desai Neil P. (Los Angeles CA) Soon-Shiong P. (Los Angeles CA) Sandford Paul A. (Los Angeles CA)
출원인 / 주소
  • Vivorx, Inc. (Santa Monica CA 02)
인용정보 피인용 횟수 : 158  인용 특허 : 0

초록

In accordance with the present invention, there are provided polymeric drug delivery systems in which the drug is bound to a water-soluble polymer to provide a form of soluble drug delivery especially for those cases in which the drug by itself is water-insoluble. In particular, the drug taxol is co

대표청구항

A taxol derivative having the general formula R1-T-R2: wherein R1=-X-P or -OH, and R1 is located on the 2′-carbon of the taxol side chain; wherein R1=-X-P or -OH, and R2 is located on the 7-carbon atom of the ring structure; but R1 and R2 are not simultaneously -OH; and the drug taxol T, is covalent

이 특허를 인용한 특허 (158)

  1. Greenwald Richard B. ; Pendri Annapurna ; Choe Yun H., Acyl polymeric derivatives of aromatic hydroxyl-containing compounds.
  2. Hunter, William L.; Machan, Lindsay S.; Arsenault, A. Larry, Anti-angiogenic compositions and methods of use.
  3. Hunter, William L.; Machan, Lindsay S.; Arsenault, A. Larry, Anti-angiogenic compositions and methods of use.
  4. Hunter, William L.; Machan, Lindsay S.; Arsenault, A. Larry, Anti-angiogenic compositions and methods of use.
  5. Renier, Davide; Bettella, Fabio, Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation, and their use in the pharmaceutical field.
  6. Kiser, Patrick F.; Thomas, Allen A., Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments.
  7. Alferiev, Ivan; Levy, Robert J.; Fishbein, Ilia, Biodegradable linkers for molecular therapies.
  8. Hubbell, Jeffrey A.; Elbert, Donald; Lütolf, Matthias; Pratt, Alison; Schoenmakers, Ronald; Tirelli, Nicola; Vernon, Brent, Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups.
  9. Dixon, James Brandon; Hubbell, Jeffrey A.; O'Neil, Conlin P.; Swartz, Melody; Velluto, Diana, Block copolymers and uses thereof.
  10. Hubbell,Jeffrey A.; Napoli,Alessandro; Tirelli,Nicola, Block copolymers for multifunctional self-assembled systems.
  11. Swartz, Melody A.; Hubbell, Jeffrey A.; Tomei, Alice A.; Shields, Jacqueline D.; Kourtis, Iraklis, CCR7 ligand delivery and co-delivery in immunotherapy.
  12. Coutts,Stephen M.; Jones,David S.; Livingston,Douglas Alan; Yu,Lin, Chemically defined non-polymeric valency platform molecules and conjugates thereof.
  13. Coutts,Stephen M.; Jones,David S.; Livingston,Douglas Alan; Yu,Lin, Chemically-defined non-polymeric valency platform molecules and conjugates thereof.
  14. Lin, Hung-Yun; Davis, Faith B.; Davis, Paul J.; Mousa, Shaker A., Combination treatment of cancer with cetuximab and tetrac.
  15. Eldon, Michael A.; Harite, Shibani S.; Barker, Tamra L., Compositions and methods for achieving sustained therapeutic drug concentrations in a subject.
  16. Hubbell, Jeffrey A.; Elbert, Donald L.; Schoenmakers, Ronald, Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds.
  17. Hubbell,Jeffrey A.; Elbert,Donald; Schoenmakers,Ronald, Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds.
  18. Hubbell,Jeffrey A.; Elbert,Donald; Schoenmakers,Ronald, Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds.
  19. Boppart, Stephen A.; Xu, Chenyang, Contrast enhanced spectroscopic optical coherence tomography.
  20. Ohri, Rachit; Blaskovich, Phillip; Kennedy, Joshua; Bennett, Steven L.; Driscoll, Arthur, Crosslinked polymers with the crosslinker as therapeutic for sustained release.
  21. Ohri, Rachit; Blaskovich, Phillip; Kennedy, Joshua; Bennett, Steven L.; Driscoll, Arthur, Crosslinked polymers with the crosslinker as therapeutic for sustained release.
  22. Chari, Ravi V. J.; Miller, Michael Louis, Cytotoxic agents comprising polyethylene glycol-containing taxanes and their therapeutic use.
  23. Harris,J. Milton; Zhao,Xuan, Degradable heterobifunctional poly(ethylene glycol) acrylates.
  24. Harris,J. Milton; Zhao,Xuan, Degradable heterobifunctional poly(ethylene glycol) acrylates.
  25. J. Milton Harris ; Xuan Zhao, Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conjugates derived therefrom.
  26. Boppart, Stephen A.; Xi, Chuanwu, Device and method for imaging the ear using optical coherence tomography.
  27. Larsen, Kristian; Sabra, Mads, Device for promotion of hemostasis and/or wound healing.
  28. Marks, Daniel L.; Boppart, Stephen A., Distinguishing non-resonant four-wave-mixing noise in coherent stokes and anti-stokes Raman scattering.
  29. Niitsu, Yoshiro; Yu, Lei; Liu, Jian; Zhao, Gang; Ma, Nianchun; Van, Sang, Drug carriers.
  30. Shuichi Sugawara JP; Masahiro Kajiki JP; Hiroshi Kuriyama JP; Nobuya Kitaguchi JP, Drug complex.
  31. Larsen, Kristian, Dry composition comprising an extrusion enhancer.
  32. Larsen, Kristian, Dry haemostatic composition.
  33. Larsen, Kristian, Dry haemostatic composition.
  34. Qian, Zhen; Osawa, A. Edward; Reich, Cary J., Dry hemostatic compositions and methods for their preparation.
  35. Qian, Zhen; Osawa, A. Edward; Reich, Cary J., Dry hemostatic compositions and methods for their preparation.
  36. Qian, Zhen; Osawa, A. Edward; Reich, Cary J.; Wallace, Donald G.; Shargill, Narinder S.; Vega, Felix, Dry hemostatic compositions and methods for their preparation.
  37. Karel J. Lambert ; Panayiotis P. Constantinides ; Steven C. Quay, Emulsion vehicle for poorly soluble drugs.
  38. Lambert, Karel J.; Constantinides, Panayiotis P.; Quay, Steven C., Emulsion vehicle for poorly soluble drugs.
  39. Lambert, Karel J.; Constantinides, Panayiotis P.; Tustian, Alexander K.; Quay, Steven C., Emulsion vehicle for poorly soluble drugs.
  40. Lambert,Karel J.; Constantinides,Panayiotis P.; Quay,Steven C., Emulsion vehicle for poorly soluble drugs.
  41. Lambert,Karel J.; Constantinides,Panayiotis P.; Tustian,Alexander K.; Quay,Steven C., Emulsion vehicle for poorly soluble drugs.
  42. McIver John McMillan ; Underiner Todd Laurence ; Bates Timothy, Enzyme Inhibitors.
  43. McIver John McMillan ; Underiner Todd Laurence ; Bates Timothy, Enzyme inhibitors.
  44. Anand C. Burman IN; Rama Mukherjee IN; Dhiraj Khattar IN; Mukesh Kumar IN; Honey Bala IN; Rajiv Kumar Shrivastava IN, Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof.
  45. Maitra Amarnath,INX ; Sahoo Sanjeeb Kumar,INX ; Ghosh Prasanta Kumar,INX ; Burman Anand C.,INX ; Mukherjee Rama,INX ; Khattar Dhiraj,INX ; Kumar Mukesh,INX ; Paul Soumendu,INX, Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof.
  46. Wallace Donald G. ; Reich Cary J. ; Shargill Narinder S. ; Vega Felix ; Osawa A. Edward, Fragmented polymeric compositions and methods for their use.
  47. Wallace, Donald G.; Reich, Cary J.; Shargill, Narinder S.; Vega, Felix; Osawa, A. Edward, Fragmented polymeric compositions and methods for their use.
  48. Wallace, Donald G.; Reich, Cary J.; Shargill, Narinder S.; Vega, Felix; Osawa, A. Edward, Fragmented polymeric compositions and methods for their use.
  49. Wallace, Donald G.; Reich, Cary J.; Shargill, Narinder S.; Vega, Felix; Osawa, A. Edward; Qian-Wallis, Zhen, Fragmented polymeric compositions and methods for their use.
  50. Wallace, Donald G.; Reich, Cary J.; Shargill, Narinder S.; Vega, Felix; Osawa, A. Edward; Qian-Wallis, Zhen, Fragmented polymeric compositions and methods for their use.
  51. Reich, Cary J.; Osawa, A. Edward; Tran, Helen, Hemoactive compositions and methods for their manufacture and use.
  52. Reich,Cary J.; Osawa,A. Edward; Tran,Helen, Hemoactive compositions and methods for their manufacture and use.
  53. Hedrich, Hans Christian; Hoefinghoff, Joris; Gorna, Katarzyna, Hemostatic compositions.
  54. McCoy, Jill; Dwyer, Joseph F.; Yang, Ziping, Hemostatic compositions.
  55. Pendharkar, Sanyog M.; Gorman, Anne J., Hemostatic compositions containing sterile thrombin.
  56. Hedrich, Hans Christian; Hoefinghoff, Joris, Hemostatic sponge.
  57. Hedrich, Hans Christian; Hoefinghoff, Joris, Hemostatic sponge.
  58. Hedrich, Hans Christian; Hoefinghoff, Joris; Rhee, Woonza M.; Osawa, Atsushi Edward, Hemostatic sponge.
  59. Hedrich, Hans Christian; Hoefinghoff, Joris; Rhee, Woonza M.; Osawa, Atsushi Edward, Hemostatic sponge.
  60. Hedrich, Hans Christian; Hoefinghoff, Joris; Rhee, Woonza M.; Osawa, Atsushi Edward, Hemostatic sponge.
  61. Hoefinghoff, Joris; Hedrich, Hans Christian, Hemostatic sponge.
  62. Nho, Kwang; Chang-min, Hyun; Lee, Jung-Hun; Kim, In-Kyung; Pak, Young-Kyoung, Hexa-arm polyethylene glycol and its derivatives and the methods of preparation thereof.
  63. Bouhadir,Kamal H.; Kruger,Genevieve M.; Mooney,David J., Hydrogels and water soluble polymeric carriers for drug delivery.
  64. Winther, Lars; Lohse, Jesper; Gabs, Susanne; Petersen, Kenneth Heesche, Immunohistochemistry and in situ hybridization detection method.
  65. Winther, Lars; Lohse, Jesper; Gabs, Susanne; Petersen, Kenneth Heesche, Immunohistochemistry detection method.
  66. Winther, Lars; Lohse, Jesper; Gabs, Susanne; Petersen, Kenneth Heesche, In situ hybridization detection method.
  67. Winther, Lars; Lohse, Jesper; Gabs, Susanne; Petersen, Kenneth Heesche, In situ hybridization detection method.
  68. McManus, Samuel P.; Kozlowski, Antoni; Hutchison, Tracy L.; Bray, Brian; Shen, Xiaoming, Intermediates useful in the preparation of maleimide functionalized polymers.
  69. McManus, Samuel P.; Kozlowski, Antoni; Hutchison, Tracy L.; Bray, Brian; Shen, Xiaoming, Intermediates useful in the preparation of maleimide functionalized polymers.
  70. McManus, Samuel P.; Kozlowski, Antoni; Hutchison, Tracy L.; Bray, Brian; Shen, Xiaoming, Intermediates useful in the preparation of maleimide functionalized polymers.
  71. McManus, Samuel P.; Kozlowski, Antoni; Hutchison, Tracy L.; Bray, Brian; Shen, Xiaoming, Intermediates useful in the preparation of maleimide functionalized polymers.
  72. Boppart, Stephen A.; Nguyen, Freddy T.; Zysk, Adam M., Low-coherence interferometry and optical coherence tomography for image-guided surgical treatment of solid tumors.
  73. Oldenburg, Amy L.; Boppart, Stephen A.; Crecea, Vasilica; Liang, Xing, Magnetomotive optical coherence tomography.
  74. Zysk, Adam M.; Adie, Steven G.; Leigh, Matthew S.; Armstrong, Julian J.; Sampson, David D.; Boppart, Stephen A., Method and apparatus for measurement of optical properties in tissue.
  75. Mousa, Shaker A.; Davis, Paul J., Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders.
  76. Mousa, Shaker A.; Davis, Paul J., Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disorders.
  77. Odar, Johann; Nistor-Gallo, Raymond, Method for directed cell in-growth and controlled tissue regeneration in spinal surgery.
  78. Benet Leslie Z. ; Wu Chi Yuan, Method for increasing bioavailability of oral pharmaceutical compositions.
  79. Benet Leslie ; Wu Chi Yuan, Method for increasing bioavailability of orally administered pharmaceutical compounds.
  80. Zhang, Wen, Method for preparing a polymer conjugate.
  81. Zhang, Wen, Method for preparing a polymer conjugate.
  82. Zhang, Wen, Method for preparing a polymer conjugate.
  83. Kozlowski, Antoni; Handley, John; Schaefer, Anthony G.; Bray, Brian; Odom, Ryan; Sander, Tony L., Method for preparing conjugates using polymer maleimides.
  84. Kozlowski, Antoni; Handley, John R.; Schaefer, Anthony G.; Bray, Brian; Odom, Ryan; Sander, Tony L., Method for preparing polymer maleimides.
  85. Kozlowski, Antoni; Handley, John; Schaefer, Anthony G.; Bray, Brian; Odom, Ryan; Sander, Tony L., Method for preparing polymer maleimides.
  86. Petter-Puchner, Alexander; Redl, Heinz, Method for the improvement of mesh implant biocompatibility.
  87. Petter-Puchner, Alexander; Redl, Heinz, Method for the improvement of mesh implant biocompatibility.
  88. McManus, Samuel P.; Kozlowski, Antoni; Hutchison, Tracy L.; Bray, Brian; Shen, Xiaoming, Method of preparing maleimide functionalized polymers.
  89. Ragheb,Anthony O.; Fearnot,Neal E.; Voorhees, III,William D.; Kozma,Thomas G.; Bates,Brian L.; Osborne,Thomas A., Method of treating a patient with a coated implantable medical device.
  90. Odar, Johann; Sepehrnia, Abolghassem; Schachtler, Ralph; Stemberger, Axel W., Methods for repairing and regenerating human dura mater.
  91. Mousa, Shaker A.; Davis, Paul J., Methods for screening patients for resistance to angioinhibition, treatment and prophylaxis thereof.
  92. Eldon, Michael A.; Harite, Shibani S.; Barker, Tamra L., Methods for treating humans having brain cancer.
  93. Alexander-Bridges, Maria; Mousa, Shaker A.; Davis, Paul J., Methods of stimulating fat mobilization using a polymer conjugated polyphenol.
  94. Ng, Steven Y.; Shen, Hui-Rong; Heller, Jorge, Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron.
  95. Masters, Ronald Anthony; Hillshafer, Douglas Kip; Gariepy, Christopher A., Multi-arm hydrophilic urethane polymers, methods of making them, and compositions and processes employing them.
  96. Zhao, Xuan; Bentley, Michael D.; Ren, Zhongxu; Viegas, Tacey X., Multi-arm polymer prodrugs.
  97. Zhao, Xuan; Bentley, Michael D.; Ren, Zhongxu; Viegas, Tacey X., Multi-arm polymer prodrugs.
  98. Zhao, Xuan; Bentley, Michael D.; Ren, Zhongxu; Viegas, Tacey X., Multi-arm polymer prodrugs.
  99. Zhao, Xuan; Bentley, Michael David; Ren, Zhongxu; Viegas, Tacey X., Multi-arm polymer prodrugs.
  100. Zhao, Xuan; Bentley, Michael David; Ren, Zhongxu; Viegas, Tacey X., Multi-arm polymer prodrugs.
  101. Zhao, Xuan; Bentley, Michael David; Ren, Zhongxu; Viegas, Tacey X., Multi-arm polymer prodrugs.
  102. Zhao, Xuan; Bentley, Michael David; Ren, Zhongxu; Viegas, Tacey X., Multi-arm polymer prodrugs.
  103. Kozlowski, Antoni; McManus, Samuel P.; Riggs-Sauthier, Jennifer; Shen, Xiaoming; Zhang, Wen, Multi-arm polymeric alkanoate conjugates.
  104. Kozlowski, Antoni; McManus, Samuel P.; Riggs-Sauthier, Jennifer; Shen, Xiaoming; Zhang, Wen, Multi-arm polymeric alkanoate conjugates.
  105. Kozlowski, Antoni; McManus, Samuel P.; Riggs-Sauthier, Jennifer; Shen, Xiaoming; Zhang, Wen, Multi-arm polymeric alkanoate conjugates.
  106. Kozlowski, Antoni; McManus, Samuel P.; Riggs-Sauthier, Jennifer; Shen, Xiaoming; Zhang, Wen, Multi-arm polymeric alkanoate conjugates.
  107. Kozlowski, Antoni; McManus, Samuel P.; Riggs-Sauthier, Jennifer; Shen, Xiaoming; Zhang, Wen, Multi-arm polymeric alkanoate conjugates.
  108. Zhao, Hong; Rubio, Maria Belen; Wu, Dechun; Sapra, Puja, Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers.
  109. Zhao, Hong; Rubio, Maria Belen; Wu, Dechun; Sapra, Puja, Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers.
  110. Zhao,Hong; Rubio,Maria Belen; Wu,Dechun; Sapra,Puja, Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers.
  111. Kozlowski, Antoni; Riley, Timothy A.; McManus, Samuel P., Multi-arm polymeric prodrug conjugates of taxane-based compounds.
  112. Boppart, Stephen A.; Wei, Alexander, Multi-functional plasmon-resonant contrast agents for optical coherence tomography.
  113. Davis, Paul J.; Davis, Faith B.; Mousa, Shaker A.; Glinksy, Gennadi V.; Hercbergs, Aleck, Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof.
  114. Davis, Paul J.; Mousa, Shaker A., Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof.
  115. Mousa, Shaker; Davis, Paul, Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof.
  116. Mousa, Shaker A.; Davis, Faith B.; Davis, Paul J., Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof.
  117. Mousa, Shaker A.; Davis, Faith B.; Davis, Paul J., Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof.
  118. Mousa, Shaker A.; Davis, Faith B.; Davis, Paul J., Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof.
  119. Mousa, Shaker A.; Rajabi, Mehdi, Non-cleavable polymer conjugated with αVβ3 integrin thyroid antagonists.
  120. Boppart, Stephen A.; Marks, Daniel L., Nonlinear interferometric vibrational imaging.
  121. Boppart,Stephen A.; Marks,Daniel L.; Suslick,Kenneth S.; Toublan,Farah Jean Jacques, Optical contrast agents for optically modifying incident radiation.
  122. Bhatt,Rama; Vries,Peter de; Klein,J. Peter; Tulinsky,John; Lewis,Robert A.; Singer,Jack W., Polyglutamic acid-camptothecin conjugates and methods of preparation.
  123. Bhatt,Rama; Vries,Peter de; Klein,J. Peter; Tulinsky,John; Lewis,Robert A.; Singer,Jack W., Polyglutamic acid-camptothecin conjugates and methods of preparation.
  124. Mohanty,Dillip K.; Sharma,Ajit, Polyoxyalkylene compound and method for making.
  125. Nho, Kwang; Hyun, Changmin; Lee, Junghun; Pak, Youngkyoung, Preparation method of peg-maleimide derivatives.
  126. Goessl, Andreas, Process for making dry and stable hemostatic compositions.
  127. Goessl, Andreas; Osawa, Atsushi Edward; Reich, Cary J., Process for making dry and stable hemostatic compositions.
  128. Goessl, Andreas; Osawa, Atsushi Edward; Reich, Cary J., Process for making dry and stable hemostatic compositions.
  129. Goessl, Andreas; Osawa, Atsushi Edward; Reich, Cary J., Process for making dry and stable hemostatic compositions.
  130. Yukihiro Yoneda JP; Tokumasa Ishida JP; Hajime Matsumoto JP; Hidekazu Mizohara JP, Production process for hydroxyalkyl ester.
  131. Holton,Robert A.; Nadizadeh,Hossain; Yang,Li Xi, Radiosensitizing taxanes and their pharmaceutical preparations.
  132. Rhee, Woonza M.; Reich, Cary J.; Osawa, A. Edward; Vega, Felix, Rapidly acting dry sealant and methods for use and manufacture.
  133. Rhee, Woonza M.; Reich, Cary J.; Osawa, A. Edward; Vega, Felix, Rapidly acting dry sealant and methods for use and manufacture.
  134. Ng, Steven Y.; Shen, Hui Rong; Heller, Jorge, Semi-solid delivery vehicle and pharmaceutical compositions for delivery of granisetron.
  135. Suslick,Kenneth S.; Toublan,Farah Jean Jacques; Boppart,Stephen A.; Marks,Daniel L., Surface modified protein microparticles.
  136. De Luca, Gilda; Bettolo, Rinaldo Marini; Migneco, Luisa Maria, Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives.
  137. De Luca, Gilda; Bettolo, Rinaldo Marini; Migneco, Luisa Maria, Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives.
  138. Mousa, Shaker A.; Davis, Faith B.; Davis, Paul J., Thyroid hormone analogs and methods of use.
  139. Mousa, Shaker A.; Davis, Faith B.; Davis, Paul J., Thyroid hormone analogs and methods of use.
  140. Mousa, Shaker A.; Davis, Faith B.; Davis, Paul J., Thyroid hormone analogs and methods of use.
  141. Mousa, Shaker A.; Davis, Faith B.; Davis, Paul J., Thyroid hormone analogs and methods of use.
  142. Sapra, Puja, Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin.
  143. Sapra, Puja, Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamtothecin.
  144. Segura, Tatiana; Hubbell, Jeffrey A., Triblock copolymers for cytoplasmic delivery of gene-based drugs.
  145. Kauvar Lawrence M. ; Lyttle Matthew H. ; Satyam Apparao, Urethane mediated, GST specific molecular release systems.
  146. Odar, Johann; Nistor-Gallo, Raymond; Caliari, Laura, Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects.
  147. Davis, Paul J.; Mousa, Shaker A., Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells.
  148. Larsen, Kristian; Mortensen, Michael Wrang, Vacuum expanded dry composition and syringe for retaining same.
  149. Asgharian, Bahram; Chowhan, Masood A.; Wax, Martin B., Water insoluble polymer matrix for drug delivery.
  150. Chun Li ; Sidney Wallace ; Dong-Fang Yu ; David J. Yang, Water soluble paclitaxel derivatives.
  151. Li, Chun; Wallace, Sidney; Yu, Dong-Fang; Yang, David J., Water soluble paclitaxel derivatives.
  152. Li,Chun; Wallace,Sidney; Yu,Dong Fang; Yang,David, Water soluble paclitaxel derivatives.
  153. Li,Chun; Wallace,Sidney; Yu,Dong Fang; Yang,David J., Water soluble paclitaxel derivatives.
  154. Li Chun ; Wallace Sidney ; Yu Dong-Fang ; Yang David J., Water soluble paclitaxel prodrugs.
  155. Li,Chun; Wallace,Sidney; Yu,Dong Fang; Yang,David J., Water soluble paclitaxel prodrugs.
  156. Maitra, Anirban; Feldmann, Georg; Bisht, Savita, Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles.
  157. Maitra, Anirban; Feldmann, Georg; Bisht, Savita, Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles.
  158. Michael David Bentley ; Xuan Zhao ; Jeremy Lloyd Clark, Water-soluble polymer conjugates of artelinic acid.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로